ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anders Jeppsson
Rolf Ekroth
Folke N. Nilsson
Sveneric Svensson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeppsson, A.
Right arrow Articles by Wernerman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeppsson, A.
Right arrow Articles by Wernerman, J.

Ann Thorac Surg 1998;65:684-690
© 1998 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Renal Effects of {alpha}-Ketoglutarate Early After Coronary Operations

Anders Jeppsson, MD, Rolf Ekroth, MD, Peter Friberg, MD, Klaus Kirnö, MD, Italo Milocco, MD, Folke N. Nilsson, MD, PhD, Sveneric Svensson, MD, Jan Wernerman, MD, PhD

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg, Sweden

Accepted for publication August 29, 1997.

Dr Jeppsson, Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden (e-mail: rolf.ekroth@hjl.gu.se).

Background. {alpha}-Ketoglutarate ({alpha}-KG) is a Krebs cycle intermediate and the carbon skeleton of glutamate. {alpha}-Ketoglutarate has provoked interest in heart surgery because of its proposed critical role in myocardial metabolism. This study investigates the role of {alpha}-KG in renal function after cardiac surgical procedures.

Methods. Twenty-two patients with normal preoperative renal function were included in a prospective, randomized, and controlled study. Eleven patients received intravenous infusion of 30 g {alpha}-KG/hour after the operation. Measurements were performed before operation, immediately after operation, and after 30 minutes of {alpha}-KG infusion.

Results. Renal blood flow was higher during {alpha}-KG infusion, 297% ± 97% (of preoperative value), than in controls, 125% ± 20% (p < 0.05). Filtration fraction was lower (12.3% ± 0.05% versus 17.2% ± 1.1%, p < 0.01), which prevented a significant difference in glomerular filtration rate. The renal arteriovenous differences of lactate, glutamate, glutamine, and glycine changed toward a net release during {alpha}-KG infusion.

Conclusions. Infusion of {alpha}-KG enhances renal blood flow early after coronary surgical procedures in patients with normal renal function. The mechanism is unclear, but could be associated with primarily metabolic effects, and may potentially convey a beneficial effect for renal function.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.